We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nanoprinter to Mass-Produce NanoDevices

By Biotechdaily staff writers
Posted on 28 Jun 2005
A new "nano-printing” technique could enable the mass-production of nano-devices manufactured one at a time.

Clearly the most immediate candidate for this technology is the DNA microarray, nano-devices utilized to identify and evaluate genetic disorders including viral illnesses such as AIDs, Alzheimer's disease, and certain kinds of cancer. More...
The capability to generate these complicated devices would make DNA analysis as ordinary and economical as blood testing, thereby significantly speeding up efforts to understand the mechanisms of disease.

The demand for smaller devices of increasing complexity in areas from biomedicine to information technology has prompted several research efforts toward high-resolution, high-throughput nano-printing techniques. Researchers led by Prof. Francesco Stellacci, from the department of materials science and engineering at the Massachusetts Institute of Technology (MIT, Boston, MA, USA) have developed a printing method that is unrivaled in both information content per printing cycle and resolution. They achieved the latter using what Arum Amy Yu, an MIT graduate student and member of the research team, calls "nature's most efficient printing technique: the DNA/RNA information transfer.”

In the new printing technique, called supramolecular nano-stamping (SuNS), single strands of DNA basically self-assemble upon a surface to copy a nano-scale pattern made of their complementary DNA strands. The duplicates are identical to the master and can therefore be used as masters themselves. This increases print output exponentially while enabling the reproduction of very complicated nano-scale patterns.

One of these patterns is found on a DNA microarray, a glass chip or silicon printed with up to 500,000 tiny dots. Each dot is made up of multiple DNA molecules of known sequence, i.e., a snippet of an individual's genetic code. Researchers use DNA microarrays to find and analyze a person's DNA or messenger-RNA genetic code. Frequent, widespread use of these devices is complicated by the fact that producing them is a painstaking process that involves at least 400 printing steps and costs about U.S.$500 per microarray.

MIT's nano-printing technique requires only three steps and could reduce the cost of each microarray to under U.S.$50. "This would completely revolutionize diagnostics,” said Prof. Stellacci. With the ability to mass-produce these devices and thereby make DNA analysis routine, "we could know years in advance of cancer, hepatitis, or Alzheimer's.”

Another advantage would be large-scale diagnostics that could provide beneficial data about disease processes such as diabetes. "We don't know if it's genetic. The only way to find out is to test a lot of people,” said Prof. Stellacci. "The more we test with microarrays, the more we know about illnesses, and the more we can detect them.”

SuNS has applications beyond DNA microarrays. Materials both organic and inorganic (i.e., metal nanoparticles) can be made to assemble along a pattern comprised of DNA strands. This makes SuNS a versatile method that could be used to produce other complex nano-devices currently manufactured slowly and expensively: micro- and nano-fluidics channels, single-electron transistors, metallic wires, and optical biosensors.

A report on the technology was published in May 2005 in the online section of the journal Nano Letters.




Related Links:
Massachusetts Institute of Technology >

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LIAISON Murex Anti-HDV Immunoassay is the first fully automated FDA-authorized immunoassay for HDV detection in the U.S. (Photo courtesy of Diasorin)

Fully Automated Immunoassay Test Detects HDV Co‑Infection and Super-Infection

Hepatitis delta, also known as hepatitis D, is caused by the hepatitis delta virus (HDV). It is a viral liver infection that can result in one of the most severe forms of viral hepatitis.... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.